Multimodal imaging in deferasirox-mediated retinopathy

Introduction Deferasirox is the only iron chelator available in oral formulation and a rare cause of pigmentary retinopathy. We report the first case of multimodal imaging in an adult with deferasirox retinopathy. Methods Case report and literature review, with search terms including deferasirox ret...

Full description

Saved in:
Bibliographic Details
Published in:European journal of ophthalmology 2024-07, Vol.34 (4), p.NP33-NP37
Main Authors: Caranfa, Jonathan, Carrera, William, Marmalidou, Anna, Desai, Shilpa, Baumal, Caroline
Format: Article
Language:English
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Introduction Deferasirox is the only iron chelator available in oral formulation and a rare cause of pigmentary retinopathy. We report the first case of multimodal imaging in an adult with deferasirox retinopathy. Methods Case report and literature review, with search terms including deferasirox retinopathy and deferasirox toxicity. Results A 63-year-old man with end stage renal disease and transfusion-dependent anemia on deferasirox for one year presented with asymptomatic pigment epitheliopathy. Optical coherence tomography featured outer retinal and retinal pigment epithelial discontinuity corresponding to hypoautofluorescence on fundus autofluorescence and blocking on fluorescein angiography. Multifocal electroretinography revealed subtle reduction in all amplitudes. Conclusions Retinal examinations should be considered for patients requiring chronic administration of deferasirox.
ISSN:1120-6721
1724-6016
DOI:10.1177/11206721241245740